Inhibition of Both Activated p38 Mapkα and mTORC1 Potentiates the Effect of SR1 on Promoting Hematopoietic Reconstitution of Ex Vivo Expanded Human Umbilical Cord Blood Hematopoietic Stem Cells

离体 造血 干细胞 生物 脐带血 移植 细胞生物学 mTORC1型 PI3K/AKT/mTOR通路 免疫学 癌症研究 体内 内科学 医学 信号转导 生物技术
作者
Xiao Ma,Xiaoyi Li,Peng Danyue,Huifang Wang,Lei Li,Hao Zhou,Daohong Zhou,Yi Luo,Lingbo Liu
出处
期刊:Blood [Elsevier BV]
卷期号:128 (22): 2173-2173
标识
DOI:10.1182/blood.v128.22.2173.2173
摘要

Abstract Hematopoietic stem cells (HSCs) transplantation is a curative treatment for various hematological disorders. However, its use has been limited in part by the difficulty to obtain sufficient numbers of transplantable HSCs, especially from human umbilical cord bloods (hUCBs). Ex vivo expansion of cord blood HSCs can potentially mitigate the shortfall if the expanded HSCs can maintain their stemness for long-term hematopoietic reconstitution. Our previous studies have shown that some hUCB HSCs lose their "stemness" during ex vivo expansion in part due to induction of cellular senescence via p38MAPKα(p38) or mTORC1 activation and inhibition of p38 and mTOR C1 promotes HSCs expansion (Ann Hematol. 2012; 91:813-823; Transplantation. 2014; 97:20-29). Recently, it was shown that StemRegenin 1 (SR1), an antagonist of the aryl hydrocarbon receptor (AHR), could significantly promote ex vivo expansion of HSCs, primarily via inhibition of HSCs differentiation. Therefore, we investigated whether the combination of SR1 with LY2228820 (LY) and rapamycin (Rapa) to inhibit p38 and mTOR C1, respectively, can enhance ex vivo expansion of hUBC HSCs by inhibiting HSCs differentiation and senescence. Next, we confirmed that co-inhibition of activated p38 and mTORC1 promotes SR1 induced HSCs expansion ex vivo through inhibition of senescence.Our combined culture system in 7 days led to a 16.2-fold increase for CD34+CD90+ subpopulation and a 6.1-fold increase for CD34+CD45RA- subpopulation compared to input cells (Blood,126(23):381-381) .To determine the hematopoietic reconstitution ability of the progeny of hUCB CD34+ cells expanded with inhibitors of p38, mTORC1, and AHR, we transplanted 1000 to 30000 uncultured hUCB CD34+ cells or a fraction of the final culture equivalent to 1000 to 10000 starting hUCB CD34+ cells into sub-lethally irradiated 6 to 10-week-old NOD-Prkdcscid Il2rgnull (NOG) mice. Donor cell engraftment was analyzed at 8 and 13 weeks after the transplantation. The results showed that the progeny of 10,000 hUCB CD34+ cells cultured with LY, Rapa and SR1 produced significant greater donor cell engraftment in the recipients' peripheral blood compared with the same number of un-cultured hUCB CD34+ cells (2.19-fold, p<0.01), the progeny of 10,000 hUCB CD34+ cells cultured with vehicle (2.76-fold, p<0.01), or the progeny of 10,000 hUCB CD34+ cells cultured with SR1 alone (1.72-fold, p<0.05). The similar results were also found in the recipients' bone marrow and spleen. In addition, the progeny of 3,000 hUCB CD34+ cells cultured with LY, Rapa and SR1 generated the levels of peripheral blood donor cell engraftment that similar to these produced by 30,000 un-cultured hUCB CD34+ cells and the progeny of 10,000 hUCB CD34+ cells cultured with SR1 alone. More importantly, the hUCB CD34+ cells cultured with LY, Rapa and SR1 retained multi-lineage differentiation potential as they were able to produce human B cells, myeloid cells, red blood cell progenitors, megakaryocytes, and NK cells in the recipients' bone marrow. Furthermore, hUCB CD34+ cells cultured with LY, Rapa and SR1 produced the highest levels of human HSCs (CD34+CD38-/CD34+CD90+/CD34+CD45RA- cells) engraftment compared to all other cells. Collectively, these findings suggest that the combined inhibition of p38, mTORC1 and AHR is more effective in promoting the expansion and hematopoietic reconstitution of hUBC HSCs than inhibition of p38, mTORC1 or ARH alone probably via inhibition of HSCs senescence and differentiation. This new strategy may alleviate the limitation of hUBC for transplantation in adult patients. Disclosures No relevant conflicts of interest to declare.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
啵噜噜噜啊完成签到,获得积分10
3秒前
OYY完成签到 ,获得积分10
3秒前
烂漫的断秋完成签到 ,获得积分10
4秒前
5秒前
5秒前
Lucas应助Livrik采纳,获得10
6秒前
cyn0762完成签到,获得积分10
6秒前
点到为止完成签到,获得积分10
7秒前
8秒前
Akim应助lll采纳,获得10
9秒前
高贵灵槐完成签到 ,获得积分10
10秒前
13秒前
wxh完成签到 ,获得积分20
13秒前
量子星尘发布了新的文献求助10
13秒前
liuzi发布了新的文献求助20
14秒前
雨过天晴完成签到,获得积分10
15秒前
花花完成签到 ,获得积分10
16秒前
17秒前
19秒前
汪汪发布了新的文献求助10
22秒前
22秒前
23秒前
26秒前
追寻筮关注了科研通微信公众号
26秒前
miaojuly发布了新的文献求助10
27秒前
充电宝应助汪汪采纳,获得10
28秒前
29秒前
涵哈哈哈哈哈完成签到 ,获得积分10
31秒前
33秒前
liuzi完成签到,获得积分10
33秒前
科目三应助油菜的星星采纳,获得10
35秒前
35秒前
35秒前
36秒前
36秒前
木心应助高院士采纳,获得60
37秒前
37秒前
37秒前
38秒前
搜集达人应助卢敏明采纳,获得10
38秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988868
求助须知:如何正确求助?哪些是违规求助? 3531255
关于积分的说明 11253071
捐赠科研通 3269858
什么是DOI,文献DOI怎么找? 1804822
邀请新用户注册赠送积分活动 881994
科研通“疑难数据库(出版商)”最低求助积分说明 809035